Researchers studied the role of cannabidiol (CBD) in treating neurodegenerative disorders through its antioxidant, anti-inflammatory, and neuroprotective properties. CBD shows promise in inhibiting protein aggregation, free radicals, and neuroinflammation, making it a potential therapeutic option for conditions like Alzheimer's and Parkinson's.
Researchers found that hop bitter acids from hops improved lipid and carbohydrate metabolism in obese mice, stabilizing glycemia levels and weight gain while enhancing antioxidant capacity and brain health. This suggests potential benefits for managing obesity-related complications and cognitive decline.
OFIF, a potential nutraceutical, shows promise in addressing oxyinflammatory-based diseases at both peripheral and central levels. It may mitigate Metabolic Syndrome risks and improve cognitive function in key brain regions.
Researchers investigated potential therapeutic strategies for Alzheimer's disease due to its high prevalence and lack of cure.Understanding these strategies is crucial for developing effective treatments for the millions affected worldwide.
Researchers studied Sophora flavescens for potential anti-AD effects due to its compounds. Care because it may lead to new Alzheimer's treatments.
Researchers studied the effects of Magnolia officinalis on various health conditions. Active ingredients show potential for antibacterial, anti-tumor, anti-inflammatory, antioxidant, anti-aging, and anti-Alzheimer's effects. Promising for future treatments.
Study found that ginsenoside Rg1 and PNS from plant relieved depression symptoms in rats. Precise LC-ESI-MS/MS analysis showed positive effects on behavior and hormone levels. Potential antidepressant for humans.
Nodal regions in the nervous system are vulnerable to diabetes. Administering NS and CA to hyperglycemic mice improved memory, myelin loss, and synaptic function, suggesting potential benefits for diabetic patients.